A
Aaron J. Kowalski
Researcher at JDRF
Publications - 29
Citations - 5773
Aaron J. Kowalski is an academic researcher from JDRF. The author has contributed to research in topics: Type 1 diabetes & Diabetes mellitus. The author has an hindex of 18, co-authored 28 publications receiving 3640 citations.
Papers
More filters
Journal ArticleDOI
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino,Thomas Danne,Richard M. Bergenstal,Stephanie A. Amiel,Roy W. Beck,Torben Biester,Emanuele Bosi,Bruce A. Buckingham,William T. Cefalu,Kelly L. Close,Claudio Cobelli,Eyal Dassau,J. Hans DeVries,Kim C. Donaghue,Klemen Dovc,Francis J. Doyle,Satish K. Garg,George Grunberger,Simon Heller,Lutz Heinemann,Irl B. Hirsch,Roman Hovorka,Weiping Jia,Olga Kordonouri,Boris Kovatchev,Aaron J. Kowalski,Lori M. Laffel,Brian J. Levine,Alexander Mayorov,Chantal Mathieu,Helen R. Murphy,Revital Nimri,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,David Rodbard,Banshi Saboo,Desmond A. Schatz,Keaton C. Stoner,Tatsuiko Urakami,Stuart A. Weinzimer,Moshe Phillip,Moshe Phillip +42 more
TL;DR: This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Journal ArticleDOI
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne,Revital Nimri,Tadej Battelino,Richard M. Bergenstal,Kelly L. Close,J. Hans DeVries,Satish K. Garg,Lutz Heinemann,Irl B. Hirsch,Stephanie A. Amiel,Roy W. Beck,Emanuele Bosi,Bruce A. Buckingham,Claudio Cobelli,Eyal Dassau,Francis J. Doyle,Simon Heller,Roman Hovorka,Weiping Jia,Timothy W. Jones,Olga Kordonouri,Boris P. Kovatchev,Aaron J. Kowalski,Lori M.B. Laffel,David M. Maahs,Helen R. Murphy,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,Banshi Saboo,Mauro Scharf,William V. Tamborlane,Stuart A. Weinzimer,Moshe Phillip +33 more
TL;DR: This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
Journal ArticleDOI
Exercise management in type 1 diabetes: a consensus statement.
Michael C. Riddell,Ian W. Gallen,Carmel E. Smart,Craig E. Taplin,Peter Adolfsson,Alistair N Lumb,Aaron J. Kowalski,Rémi Rabasa-Lhoret,Rory J. McCrimmon,Carin Hume,Francesca Annan,Paul A. Fournier,Claudia Graham,Bruce W. Bode,Pietro Galassetti,Pietro Galassetti,Timothy W. Jones,Timothy W. Jones,Timothy W. Jones,Inigo San Millan,T. Heise,Anne L. Peters,Andreas Petz,Lori M.B. Laffel,Lori M.B. Laffel +24 more
TL;DR: This Review provides an up-to-date consensus on exercise management for individuals with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise, and nutritional and insulin dose adjustments to protect against exercise-related glucose excursions.
Journal ArticleDOI
International consensus on use of continuous glucose monitoring
Thomas Danne,Revital Nimri,Tadej Battelino,Richard M. Bergenstal,Kelly L. Close,J. Hans DeVries,Satish K. Garg,Lutz Heinemann,Irl B. Hirsch,Stephanie A. Amiel,Roy W. Beck,Emanuele Bosi,Bruce A. Buckingham,Claudio Cobelli,Eyal Dassau,Francis J. Doyle,Simon Heller,Roman Hovorka,Weiping Jia,Timothy W. Jones,Olga Kordonouri,Boris P. Kovatchev,Aaron J. Kowalski,Lori M.B. Laffel,David M. Maahs,Helen R. Murphy,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,Banshi Saboo,Mauro Scharf,William V. Tamborlane,Stuart A. Weinzimer,Moshe Phillip +33 more
TL;DR: In this article, the authors summarized the ATTD consensus recommendations and represented the current understanding of how CGM results can affect outcomes, as well as the current criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies.
Journal ArticleDOI
The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
Roy W. Beck,Irl B. Hirsch,Lori M.B. Laffel,William V. Tamborlane,Bruce W. Bode,Bruce A. Buckingham,Peter Chase,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Elbert S. Huang,Craig Kollman,Aaron J. Kowalski,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,Tim Wysocki,Dongyuan Xing +25 more
TL;DR: The weight of evidence suggests that CGM is beneficial for individuals with type 1 diabetes who have already achieved excellent control with A1C <7.0% and most outcomes, including those combining A 1C and hypoglycemia, favored the CGM group.